Given its pivotal role in the proliferation, survival, and activation of CD8+ T cells and NK cells, IL-15 has been identified as an antitumor cytokine in several cancers, including neuroblastoma, HCC, and breast and colorectal cancer [27–31]. This evidence concerns the gene CD8A and cancer.